Latest Articles
‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year - The Guardian
‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year The Guardian
Published: July 1, 2026, 8:26 a.m.
Ben Smith: How could the statutory menstrual leave debate impact workplace policy? - employeebenefits.co.uk
Ben Smith: How could the statutory menstrual leave debate impact workplace policy? employeebenefits.co.uk
Published: July 1, 2026, 8 a.m.
‘Life saving’ drug for people with opioid dependency to be pulled from Australia by end of year - The Guardian
‘Life saving’ drug for people with opioid dependency to be pulled from Australia by end of year The Guardian
Published: July 1, 2026, 7:57 a.m.
Mayo producer brings powerful endometriosis story to the big screen - The Mayo News
Mayo producer brings powerful endometriosis story to the big screen The Mayo News
Published: July 1, 2026, 7:30 a.m.
Inside the Nairobi Summit Exposing Africa's Women's Health Funding Crisis - streamlinefeed.co.ke
Inside the Nairobi Summit Exposing Africa's Women's Health Funding Crisis streamlinefeed.co.ke
Published: July 1, 2026, 6:35 a.m.
The Male Politicians Dictating Kenya's Uterus Policies - streamlinefeed.co.ke
The Male Politicians Dictating Kenya's Uterus Policies streamlinefeed.co.ke
Published: July 1, 2026, 6:30 a.m.
‘Lifesaver’ opioid disorder treatment pulled from Australia - Royal Australian College of General Practitioners (RACGP)
‘Lifesaver’ opioid disorder treatment pulled from Australia Royal Australian College of General Practitioners (RACGP)
Published: July 1, 2026, 6:05 a.m.
Eli Lilly invests $40M in Absci for AI-designed injectable antibody ABS-201 - Bitget
Eli Lilly invests $40M in Absci for AI-designed injectable antibody ABS-201 Bitget
Published: July 1, 2026, 2:43 a.m.
Doorstop - Parliament House - Department of the Prime Minister and Cabinet
Doorstop - Parliament House Department of the Prime Minister and Cabinet
Published: July 1, 2026, 1:53 a.m.
Cartherics emerges as Asia Pacific leader in off the shelf immune cell therapy - PharmaDispatch
Cartherics emerges as Asia Pacific leader in off the shelf immune cell therapy PharmaDispatch
Published: July 1, 2026, 1:09 a.m.
Link copied to clipboard!